KEAP1 and neoplasm: Although strategies inhibiting Nrf2 have gained focus as anticancer therapy [44, 45], yet its tumor suppressor role cannot be negated and there are still a number of studies focusing on developing small molecules that could inhibit Nrf2-KEAP1 interaction [17, 46–51].